Cleared Traditional

ElastiMed SACS (K232300) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K232300 · Elastimed , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
143d
Days
Class 2
Risk

K232300 is an FDA 510(k) clearance for the ElastiMed SACS. Classified as Sleeve, Limb, Compressible (product code JOW), Class II - Special Controls.

Submitted by Elastimed , Ltd. (Yokneam Ilit, IL). The FDA issued a Cleared decision on December 22, 2023 after a review of 143 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Elastimed , Ltd. devices

Submission Details

510(k) Number K232300 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 2023
Decision Date December 22, 2023
Days to Decision 143 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d slower than avg
Panel avg: 125d · This submission: 143d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JOW Sleeve, Limb, Compressible
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Hogan Lovells US LLP
John J Smith

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JOW Sleeve, Limb, Compressible

All 91
Devices cleared under the same product code (JOW) and FDA review panel - the closest regulatory comparables to K232300.
DVT Motion Pneumatic Compression Device
K232270 · Koge Micro Tech Co., Ltd. · Mar 2024
Lymphedema Compression
K240011 · Jkh Health Co., Ltd. · Feb 2024
Dayspring
K223228 · Koya Medical, Inc. · Jan 2024
MedHealth DVT compression Devices MHH900S/MHH900E
K231801 · Medhealth Medical Limited · Dec 2023
AeroDVx Arm System
K222823 · Sun Scientific, Inc. · Sep 2023
LEGACY® IPC
K232006 · Ig Technology, Ltd. · Aug 2023